Type(s) of colorectal cancer (CRC)-Adenocarcinoma of the rectum - Page 2 of 18 Posts on Medivizor
Navigation Menu

Type(s) of colorectal cancer (CRC)-Adenocarcinoma of the rectum Posts on Medivizor

What factors can influence ileostomy closure time after colorectal surgery?

What factors can influence ileostomy closure time after colorectal surgery?

Posted by on Jan 26, 2021 in Colorectal cancer | 0 comments

In a nutshell This study evaluated reasons for a delay to ileostomy closure in patients who underwent anterior resection for rectal cancer. This study showed that factors such as having chemotherapy or cancer progression may delay ileostomy closure. Some background The go-to surgical treatment for cancer of the middle and lower rectum involves...

Read More

Cetuximab combined with irinotecan improves the outcomes of patients with advanced colorectal cancer

Cetuximab combined with irinotecan improves the outcomes of patients with advanced colorectal cancer

Posted by on Dec 20, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of irinotecan (Camptosar) with and without cetuximab (Erbitux) in the treatment of metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that combined treatment improves the outcomes of these patients. Some background Colorectal cancer (CRC) is one of...

Read More

Evaluating cachexia after first-line treatment for patients with colorectal cancer

Evaluating cachexia after first-line treatment for patients with colorectal cancer

Posted by on Dec 5, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the occurrence of cachexia (CX; weight loss and muscle wasting) in patients with advanced colorectal cancer after first-line therapy. Researchers suggested that CX is present in half of these patients within 24 weeks after starting first-line therapy. Some background Colorectal cancer is the third most common...

Read More

Three different treatments for metastatic colorectal cancer: a comparison.

Three different treatments for metastatic colorectal cancer: a comparison.

Posted by on Oct 4, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of three different treatments for metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that fruquintinib (Elunate) was associated with the best treatment outcomes. Some background Colorectal cancer is a common cancer worldwide and 25% of patients present with...

Read More

Looking for participants to test a treatment combination for metastatic colorectal cancer

Looking for participants to test a treatment combination for metastatic colorectal cancer

Posted by on Aug 23, 2020 in Colorectal cancer | 0 comments

In a nutshell This phase 2 trial is examining the effectiveness of TAS-102 (Lonsurf) plus oxaliplatin (Eloxatin) in the treatment of metastatic (spread to other parts of the body) colorectal cancer. The main outcome to be measured will be the overall response to the treatment rate. This study is being conducted in New Jersey, US. The details...

Read More

S1-based chemotherapy improves the outcomes of patients with advanced colorectal cancer

S1-based chemotherapy improves the outcomes of patients with advanced colorectal cancer

Posted by on Jun 25, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness and safety of two different chemotherapies in the treatment of advanced colorectal cancer (CRC). Researchers suggested that S1-based chemotherapy is a good option for the treatment of these patients. Some background CRC is one of the most common cancers worldwide. The standard treatment is surgery...

Read More

Evaluating minimally invasive surgery for patients with rectal cancer

Evaluating minimally invasive surgery for patients with rectal cancer

Posted by on May 31, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of minimally invasive surgery in rectal cancer. Researchers suggested that less invasive surgery methods can result in better short-term outcomes in appropriately selected patients. Some background Colorectal cancer is the third most common cancer in the US. Rectal cancer comprises around 20% of...

Read More

Cytokine-induced killer cell immunotherapy after surgery improves the outcomes of advanced colorectal cancer

Cytokine-induced killer cell immunotherapy after surgery improves the outcomes of advanced colorectal cancer

Posted by on May 31, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of the combined treatment with cytokine-induced killer cell (CIKC) immunotherapy and chemotherapy after surgery in colorectal cancer. Researchers suggested that this therapy improves treatment outcomes in patients with colorectal cancer. Some background Colorectal cancer is one of the most common...

Read More

The effectiveness and safety of regorafenib in older patients with advanced pretreated colorectal cancer

The effectiveness and safety of regorafenib in older patients with advanced pretreated colorectal cancer

Posted by on May 24, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of regorafenib (Stivarga) treatment in older patients with colorectal cancer (CRC). Researchers suggested that this treatment has similar effects in younger and older patients. Some background CRC is the third most common cancer worldwide. More than half are diagnosed in patients older...

Read More

How common are late side effects after radiation treatment for rectal cancer?

Posted by on May 9, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the frequency of late gastrointestinal (GI) side effects after radiation therapy (RT) for rectal cancer. Researchers suggested that after the improvement of RT methods these side effects are less frequent and less severe. Some background Colorectal cancer is one of the most frequently diagnosed cancers in the...

Read More

Pelvic radiotherapy followed by systemic therapy and surgery improves survival in patients with advanced rectal cancer

Posted by on Feb 22, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of pelvic radiotherapy (PRT) followed by chemotherapy and surgery in advanced rectal cancer. Researchers suggested that this combined treatment is associated with improved survival rates. Some background Rectal cancer affects 44,180 people each year in the US. Up to 80% of these people present...

Read More

TAS-102 plus bevacizumab treatment in patients with metastatic treatment-resistant colorectal cancer

Posted by on Feb 21, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the safety and effectiveness of TAS-102 (trifluridine-tipiracil) with and without bevacizumab (Avastin) therapy in metastatic colorectal cancer (mCRC). Researchers suggested that this combined therapy might be a good treatment option for patients with advanced CRC. Some background Colorectal cancer is the third...

Read More